Functional Electrical Stimulation in Chronic Ankle Instability (ESCAIP)

September 1, 2020 updated by: Shmuel Springer

Immediate and Long-term Effects of Gait Training With Functional Electrical Stimulation in Subjects With Chronic Ankle Instability

Individuals with chronic ankle instability (CAI) display neuromuscular deficits such as altered control of posture and gait when compared with healthy controls. These deficits may be attributed to muscle inhibition occurring after a surrounding joint structure has been damaged. Functional electrical stimulation (FES) is the application of high-intensity intermittent electrical stimuli to generate muscle contractions that may overcome inhibition, and which is coupled with a functional task such as gait.

The current study aims to investigate the short and immediate effects of FES on gait parameters and postural control in subjects with CAI. Prior to intervention, treadmill gait will be evaluated using a motion analysis system, and postural control will be evaluated in a series of tests that measure balance, reaction time to ankle perturbation and stabilization ability after jump-landing. Then, a 20 minutes gait training with an FES device will be applied. Immediate effects of the training on gait parameters will be assessed. For medium-term effects evaluation, subjects will return for additional 7 training sessions (2 per week for 4 weeks), following by a complete measurements acquisition as prior to intervention. At six months follow-up, subjects will be contacted for collecting subjective outcomes.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ariel, Israel, 40700
        • Recruiting
        • Ariel University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. A history of at least one significant ankle sprain:

    1. At least 12 months prior to participating in the study
    2. Was characterized by inflammatory symptoms (i.e. pain and swelling)
    3. Caused at least one day of decreased physical activity
  2. At least 3 months since the last acute ankle sprain that results in inflammatory symptoms and at least one interrupted day of desired physical activity.
  3. History of the previously injured ankle 'giving way' at least twice during the last 6 months, and/or 'feelings of instability' and/or recurrent sprain.
  4. Being able to bear full weight on the injured lower extremity with no more than mild discomfort.
  5. Scoring<24 in the Cumberland Ankle Instability Tool (CAIT)

Exclusion Criteria:

  1. A history of previous surgeries to a musculoskeletal structure in either lower limb.
  2. A history of a fracture requiring re-alignment
  3. Any acute injury to a lower limb in the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CAI subjects
Subjects in this group will receive eight 20-minutes gait training sessions with functional electrical stimulation.
Functional electrical stimulation (FES) is the application of high-intensity intermittent electrical stimuli to generate muscle contractions that may bypass spinal and supraspinal inhibition, and which is coupled with a functional task such as gait. Gait training will be conducted on a treadmill.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immediate change in ankle inversion angle during heel strike
Time Frame: immediately after the intervention

Ankle inversion angle at heel strike (in degrees) will be measured using Qualisys motion analysis system.

Change will be measured between pre-intervention to immediately after first intervention session to assess immediate effects of the intervention.

immediately after the intervention
Change in ankle inversion angle during heel strike at 4 weeks
Time Frame: through intervention completion, approximately at 4 weeks

Ankle inversion angle at heel strike (in degrees) will be measured using Qualisys motion analysis system.

Change will be measured between pre-intervention and after completing the entire intervention.

through intervention completion, approximately at 4 weeks
Immediate change in peroneal muscle electromyography
Time Frame: immediately after the intervention

Peroneal muscle activity will be measured (in millivolts) using Trigno EMG system during the 5% of gait cycle prior to heel strike.

Change will be measured between pre-intervention to immediately after first intervention session to assess immediate effects of the intervention.

immediately after the intervention
Change in peroneal muscle electromyography at 4 weeks
Time Frame: through intervention completion, approximately at 4 weeks

Peroneal muscle activity will be measured (in millivolts) using Trigno EMG system during the 5% of gait cycle prior to heel strike.

Change will be measured between pre-intervention and after completing the entire intervention.

through intervention completion, approximately at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Star excursion balance test (SEBT) score
Time Frame: through intervention completion, approximately at 4 weeks
The SEBT has been previously described as a postural control test that can differ between subjects with CAI and healthy controls. The test is performed with the subjects standing barefoot in the middle of a grid formed by eight tape measures extending out at 45° from each other. While the subject is balancing on one leg that is placed in the middle of the grid, the other leg has to reach as far as possible in each direction. The reached distance in centimeters is recorded, with the greater distance representing better postural stability. An average scores is calculated and normalized to the length of the subject's leg in centimeters.
through intervention completion, approximately at 4 weeks
Time to stabilization (TTS)
Time Frame: through intervention completion, approximately at 4 weeks

TTS is the time required to normalize ground reaction forces (GRF) after following a jump-landing. To measure TTS, subjects will be required to perform a single-leg drop-jump from a 40-cm box onto a force plate (Kistler, Switzerland) and keep balancing on a single leg for 20 seconds. GRF recordings will be analyzed to determine TTS in seconds in the ML and AP planes, as was previously described. Shorter duration demonstrates better postural stability. Subjects will be allowed at least 3 practice trials, following by 5 successful jumps landings. A rest period of 30 seconds will be allowed between jumps. If a subject will not be able to stabilize for at least 20 seconds, the trial will be repeated.

Lower values indicate better postural control.

through intervention completion, approximately at 4 weeks
Peroneal reaction time (PRT)
Time Frame: through intervention completion, approximately at 4 weeks

PRT is the time duration between and ankle inversion perturbation and beginning of peroneal muscle activation which is recognized using EMG. Subjects will stand on an inversion stimulator. In an unknown time, a sudden inversion perturbation will occur. Time measurement between perturbation time and muscle activation time is measured in seconds.

Lower values indicate better postural control.

through intervention completion, approximately at 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot and Ankle Ability Measure (FAAM) - questionnaire
Time Frame: through intervention completion, approximately at 4 weeks

A self-reported functional outcome measure utilized to track subjective changes in perceived pain and ankle function

Score ranges between 0-100. Higher scores represent higher levels of function, with score of 100 represents no disability.

through intervention completion, approximately at 4 weeks
Cumberland Ankle Instability Tool (CAIT) - questionnaire
Time Frame: through intervention completion, approximately at 4 weeks

A self-reported outcome measure designated for people with chronic ankle instability. Will also serve as an inclusion criteria.

Score ranges between 0-30, with lower scores indicate less ankle instability.

through intervention completion, approximately at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Shmuel Springer, PhD, Ariel University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 23, 2020

Primary Completion (Anticipated)

June 1, 2022

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

March 15, 2020

First Submitted That Met QC Criteria

March 17, 2020

First Posted (Actual)

March 19, 2020

Study Record Updates

Last Update Posted (Actual)

September 2, 2020

Last Update Submitted That Met QC Criteria

September 1, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Not decided yet, but optional to share all data after concealing subject's identifying details.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Joint Instability

Clinical Trials on Functional electrical stimulation device (NESS L300Plus, Bioness, Valencia, CA)

Subscribe